Robert Pohly’s Samlyn Capital Portfolio: 5 Dividend Stock Picks

1. Viatris Inc. (NASDAQ:VTRS)

Number of Hedge Fund Holders: 58
Samlyn Capital’s Stake Value: $34,865,000
Dividend Yield as of March 1: 4.36%

An American healthcare company, Viatris Inc. (NASDAQ:VTRS) initiated paying dividends to shareholders in the first quarter of 2021. On January 6, the company announced a 9% increase in its quarterly dividend at $0.12 per share. The stock’s dividend yield stood at 4.36, as recorded on March 1.

Viatris Inc. (NASDAQ:VTRS) is one of the recent holdings of Samlyn Capital, holding shares worth roughly $34.9 million. The company represented 0.48% of Robert Pohly’s portfolio. Recently, BMO Capital set a $19 price target on Viatris Inc. (NASDAQ:VTRS), with an Outperform rating on the shares, appreciating the company’s valuation.

By the end of Q4 2021, 58 hedge funds tracked by Insider Monkey reported owning stakes in Viatris Inc. (NASDAQ:VTRS), up from 55 in the previous quarter. The total value of these stakes is over $1.44 billion. Laurion Capital Management held the largest stake in the company in Q4, worth $464 million.

Davis Fund mentioned Viatris Inc. (NASDAQ:VTRS) in its Q3 2021 investor letter. Here is what the firm has to say:

“Also within healthcare, we own Viatris, the newly conceived union of Mylan, a generics/specialty pharma company, and Pfizer’s Upjohn business, which includes a portfolio of 20 largely off-patent branded Pfizer drugs including Lipitor, Lyrica, Norvasc and Viagra. The combined business is the largest generics/off-patent drug manufacturer in the world and is highly diversified by geography, with 70% of revenue outside the U.S.”

You can also take a look at 10 Best Value Stocks To Buy Now and 10 Best Climate Change Stocks to Buy Now

Follow Insider Monkey on Twitter